Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Feb 6, 2022; 10(4): 1190-1197
Published online Feb 6, 2022. doi: 10.12998/wjcc.v10.i4.1190
Table 1 Comparison of therapeutic effects between the two groups, n (%)
Group
Cases
Markedly effective
Efficient
Invalid
Total effective rate
Joint group532520845 (84.9)
Traditional group5016142030 (60.0)
χ28.062
P value0.005
Table 2 Comparison of thyroid volume between the two groups before and after treatment (mean ± SD)
Group
Cases
Thyroid volume
t value
P value
Before treatment
After treatment
Joint group5310.25 ± 3.216.37 ± 1.068.1420.000
Traditional group5010.87 ± 3.156.92 ± 1.038.4490.000
t value0.9812.693
P value0.1620.004
Table 3 Comparison of inflammatory indexes between the two groups before and after treatment (mean ± SD)
Group
Cases
IL-6 (pg/mL)
IL-8 (pg/mL)
Before treatment
After treatment
Before treatment
After treatment
Joint group5313.62 ± 3.566.19 ± 1.26a351.47 ± 23.89293.62 ± 20.93a
Traditional group5012.93 ± 3.177.61 ± 1.13a353.69 ± 23.12332.78 ± 87.07a
t value1.036.080.4783.179
P value0.150.0000.3160.000
Table 4 Table 4 Comparison of Serum anti-thyroglobulin, anti-thyroid peroxidase antibody, free thyroxine between the two groups before and after treatment (mean ± SD)
Group
Cases
TRAb (μ/mL)
TPOAb (μ/mL)
FT4 (pmol/L)
Before treatmentAfter treatmentBefore treatmentAfter treatmentBefore treatmentAfter treatment
Joint group53723.62 ± 124.6312.77 ± 44.73a429.48 ± 93.89238.42 ± 83.08a56.54 ± 5.5628.39 ± 4.57a
Traditional group50722.93 ± 123.2617.61 ± 104.05a429.74 ± 93.97332.78 ± 87.07a56.38 ± 5.0724.63 ± 3.96a
t value0.02819.511.9845.630.1524.451
P value0.4880.0000.4940.0000.8790.000
Table 5 Comparison of time taken for free thyroxine to return to normal between the two groups (mean ± SD)
Group
Cases
Time to return to normal (d)
Joint group5390.67 ± 8.54
Traditional group50123.5 ± 15.14
t value13.65
P value0.000